Related Experiment Video
Updated: Feb 1, 2026

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
Published on: April 18, 2025
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase
Yuanyuan Tong1, Luyang Zhou2, Limin Yang1
1State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center of Nanjing University, Nanjing 210061, China.
Background:
Type I IFN-based therapies against solid malignancies have yielded only limited success. How IFN affects tumor-associated macrophage (TAM) compartment to impact the therapeutic outcomes are not well understood.
Methods:
The effect of an IFN-inducer poly(I:C) on tumor-infiltrating monocytes and TAMs were analyzed using a transplantable mouse tumor model (LLC). In vitro culture systems were utilized to study the direct actions by poly(I:C)-IFN on differentiating monocytes.
Results:
We found that poly(I:C)-induced IFN targets Ly6C+ monocytes and impedes their transition into TAMs. Such an effect involves miR-155-mediated suppression of M-CSF receptor expression, contributing to restricting tumor growth. Remarkably, further analyses of gene expression profile of IFN-treated differentiating monocytes reveal a strong induction of Arg1 (encoding arginase-1) in addition to other classical IFN targets. Mechanistically, the unexpected Arg1 arm of IFN action is mediated by a prolonged STAT3 signaling in monocytes, in conjunction with elevated macrophage colony-stimulating factor (M-CSF) signaling. Functionally, induction of ARG1 limited the therapeutic effect of IFN, as inhibition of arginase activity could strongly synergize with poly(I:C) to enhance CD8+ T cell responses to thwart tumor growth in mice.
Conclusions:
Taken together, we have uncovered two functionally opposing actions by IFN on the TAM compartment. Our work provides significant new insights on IFN-mediated immunoregulation that may have implications in cancer therapies.
Insights
Type I interferon (IFN) therapy shows dual effects on tumor-associated macrophages (TAMs). While IFN restricts monocyte differentiation into TAMs, it also induces arginase-1, limiting therapeutic success in solid tumors.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Medicine
Background:
- Type I interferon (IFN)-based therapies have limited efficacy against solid tumors.
- The impact of IFN on tumor-associated macrophages (TAMs) and its role in therapeutic outcomes remain poorly understood.
Purpose of the Study:
- To investigate the effects of IFN on monocytes and TAMs within the tumor microenvironment.
- To elucidate the mechanisms underlying IFN's actions on TAM differentiation and function.
Main Methods:
- Utilized a transplantable mouse tumor model (LLC) treated with an IFN-inducer, poly(I:C).
- Analyzed tumor-infiltrating monocytes and TAMs.
- Employed in vitro culture systems to study direct IFN effects on differentiating monocytes.
Main Results:
- Poly(I:C)-induced IFN inhibited the differentiation of Ly6C+ monocytes into TAMs via miR-155-mediated suppression of M-CSF receptor.
- IFN treatment unexpectedly induced arginase-1 (Arg1) expression in monocytes through prolonged STAT3 and elevated M-CSF signaling.
- ARG1 induction counteracted the therapeutic benefits of IFN by suppressing CD8+ T cell responses.
Conclusions:
- IFN exhibits opposing actions on the TAM compartment: inhibiting differentiation while inducing arginase-1.
- IFN-mediated immunoregulation has complex implications for cancer therapy, suggesting arginase inhibition as a potential synergistic strategy.
More Related Videos
Related Concept Videos
Types of Signaling Molecules
Bacterial Signaling
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Yeast Signaling
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

